Polymer compound for surface modification to enhance anticancer immune function of natural killer cells
AssigneeDongguk University Industry-Academic Cooperation Foundation
InventorsKyobum KIM, Sungjun KIM, Gajendiran MANI
Life of this patent
Estimating the term…
Abstract
Provided relates to a polymer compound and a method for preparing same, the polymer compound comprising: a hydrophobic moiety that binds to natural killer cells; a cancer cell recognition moiety; and a linker, wherein the hydrophobic moiety is bound to one end of the linker, and the cancer cell recognition moiety is bound to the other end of the linker, thus recognizing natural killer cells and cancer cells.
Claims20
A polymer compound characterized by comprising:
- a hydrophobic moiety binding to natural killer cells;
- a cancer cell recognition moiety;
- and a linker comprising the structure of Chemical formula 1, wherein the hydrophobic moiety is bound to one end of the linker, and wherein the cancer cell recognition moiety is bound to the other end of the linker, thereby forming a polymer compound capable of recognizing natural killer cells and cancer cells,
- wherein, the variable “n” is an integer ranging from 30 to 50.
A preparation method of a polymer compound recognizing natural killer cells and cancer cells, the method comprising:
- (a) providing a compound represented by the following chemical formula 3 by coupling a compound represented by the chemical formula 2 to one end of a compound represented by the following chemical formula 1;
- and (b) a step of coupling an cancer cell recognition moiety to the other end of a compound represented by the chemical formula 3,
- wherein, the variable n is an integer ranging from 30 to 50, and the variable X represents one or more selected from acetyl, trifluoroacetyl, t-butoxycarbonyl (BOC), benzylcarbonyl (CBZ), and 9-fluorenylmethoxycarbonyl (Fmoc). Additionally, p is a natural number ranging from 12 to 20, and q is a natural number ranging from 12 to 20.
The pharmaceutical composition for preventing or treating cancer including a polymer compound characterized by comprising:
- a hydrophobic moiety binding to natural killer cells;
- a cancer cell recognition moiety;
- and a linker comprising the structure of Chemical formula 1, wherein the hydrophobic moiety is bound to one end of the linker, and wherein the cancer cell recognition moiety is bound to the other end of the linker, thereby forming a polymer compound capable of recognizing natural killer cells and cancer cells,
- wherein the variable “n” is an integer ranging from 30 to 50.
Dependencies are inferred from the claim text.